Comparative Pharmacology
Head-to-head clinical analysis: DUPHALAC versus NULYTELY FLAVORED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DUPHALAC versus NULYTELY FLAVORED.
DUPHALAC vs NULYTELY-FLAVORED
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Duphalac (lactulose) is a synthetic disaccharide that is not absorbed in the gastrointestinal tract. It is metabolized by colonic bacteria to short-chain fatty acids (e.g., acetic, lactic, formic acids), which lower colonic pH. This acidic environment favors the conversion of ammonia (NH3) to ammonium (NH4+), which is trapped in the colon and excreted in feces, thereby reducing systemic ammonia absorption. Additionally, the osmotic effect of lactulose and its metabolites draws water into the colon, producing a laxative effect.
NULYTELY-FLAVORED is an osmotic laxative containing polyethylene glycol (PEG) 3350 and electrolytes. It induces diarrhea by retaining water in the colon through osmotic action, thereby cleansing the bowel.
Oral: 15-30 mL once daily, may increase to 30-45 mL twice daily if needed. Rectal (enema): 150-300 mL as a single dose.
Adult dose: 4 liters of reconstituted solution orally as a single dose, or 240 mL (8 oz) every 10 minutes until 4 liters are consumed, approximately 1-1.5 hours before colonoscopy.
None Documented
None Documented
Not applicable; systemic exposure is negligible. Orally administered lactulose acts locally in the colon.
Not applicable; PEG 3350 is not significantly absorbed and does not exhibit a terminal elimination half-life in the systemic circulation. Clinical effect is due to local osmotic action in the gut.
Lactulose is not absorbed from the gastrointestinal tract; it is excreted unchanged in feces (>99%).
Primarily fecal elimination as unabsorbed PEG 3350; minimal systemic absorption (<0.06%). Renal excretion of absorbed fraction is negligible.
Category C
Category C
Osmotic Laxative
Osmotic Laxative